Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Stolar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Mayo Clinic Proceedings|November 26, 2010
Defining and achieving treatment success in patients with type 2 diabetes mellitusMark W Stolar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 20, 2002
Insulin resistance, diabetes, and the adipocyteMark W Stolar
Clinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J Chilton
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 29, 2013
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetesMark W Stolar, Michael Grimm, Steve Chen
The Journal of the American Osteopathic Association|June 18, 2010
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challengesJames R Gavin, Mark W Stolar, Jeffrey S Freeman, et al.
Journal of Managed Care Pharmacy : JMCP|August 19, 2008
Managing type 2 diabetes: going beyond glycemic controlMark W Stolar, Byron J Hoogwerf, Stephen M Gorshow, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Mayo Clinic Proceedings|November 26, 2010
Defining and achieving treatment success in patients with type 2 diabetes mellitusMark W Stolar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 20, 2002
Insulin resistance, diabetes, and the adipocyteMark W Stolar
Clinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J Chilton
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 29, 2013
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetesMark W Stolar, Michael Grimm, Steve Chen
The Journal of the American Osteopathic Association|June 18, 2010
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challengesJames R Gavin, Mark W Stolar, Jeffrey S Freeman, et al.
Journal of Managed Care Pharmacy : JMCP|August 19, 2008
Managing type 2 diabetes: going beyond glycemic controlMark W Stolar, Byron J Hoogwerf, Stephen M Gorshow, et al.
Pageof 1